AIG
RLMD icon

American International Group’s Relmada Therapeutics RLMD Stock Holding History

American International Group’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,219
Closed -$29.9K – 3154
2023
Q1 		$29.9K Buy
13,219
+263
+2% +$907 ﹤0.01% 2836
2022
Q4 		$45.2K Sell
12,956
-47
-0.4% -$413 ﹤0.01% 2776
2022
Q3 		$481K Buy
13,003
+184
+1% +$5.1K ﹤0.01% 1604
2022
Q2 		$243K Buy
12,819
+488
+4% +$10.6K ﹤0.01% 2065
2022
Q1 		$333K Buy
12,331
+4,012
+48% +$83K ﹤0.01% 1954
2021
Q4 		$187K Sell
8,319
-249
-3% -$5.54K ﹤0.01% 2411
2021
Q3 		$225K Buy
8,568
+161
+2% +$4.31K ﹤0.01% 2365
2021
Q2 		$269 Sell
8,407
-136
-2% -$4.72K ﹤0.01% 2318
2021
Q1 		$301 Buy
8,543
+22
+0.3% +$770 ﹤0.01% 2132
2020
Q4 		$273 Sell
8,521
-126
-1% -$4.33K ﹤0.01% 2104
2020
Q3 		$325K Buy
8,647
+48
+0.6% +$1.85K ﹤0.01% 1830
2020
Q2 		$385K Buy
+8,599
New +$364K ﹤0.01% 1728

Other funds holding RLMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

American International Group's RLMD Position: Q2 2023 in Review

American International Group sold out of Relmada Therapeutics (RLMD) in Q2 2023, closing a stake of 13,219 shares — an estimated $29.9K sold.

American International Group first reported a position in RLMD in Q2 2020 and held it in 12 quarters. The position peaked at $481K in Q3 2022. 95 funds tracked by Wall St. Rank hold RLMD as of Q2 2023.

  • American International Group reported no remaining Relmada Therapeutics position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 13,219 Relmada Therapeutics shares in Q2 2023, an estimated $29.9K.
  • American International Group first reported a position in Relmada Therapeutics in Q2 2020 and held it in 12 quarters.
  • American International Group's Relmada Therapeutics position peaked at $481K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.